Top Institutions in Ophthalmology
Institutions leading in myopia research typically conduct large-scale clinical trials such as ATOM and LAMP studies, develop treatment protocols, and pioneer innovations in pharmacologic and optical interventions for myopia control.
-
#1
National University of Singapore (NUS) Eye Research Institute
Singapore
NUS led the landmark ATOM (Atropine for the Treatment of Myopia) clinical trials, which established the efficacy and safety of low-dose atropine for myopia control, making it a global leader in this field.
Key Differentiators
- Ophthalmology
- Myopia Research
- Pediatric Eye Care
-
#2
The Hong Kong Polytechnic University, School of Optometry
Hong Kong
This institution conducted the LAMP (Low-concentration Atropine for Myopia Progression) study, which refined understanding of optimal atropine concentrations for myopia management with minimal side effects.
Key Differentiators
- Optometry
- Myopia Control
- Vision Science
-
#3
University of California, Berkeley, School of Optometry
Berkeley, CA
UC Berkeley is recognized for its extensive research in myopia progression mechanisms and clinical trials involving pharmacologic and optical interventions including atropine therapy.
Key Differentiators
- Optometry
- Myopia Research
- Clinical Trials
-
#4
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
As a leading academic medical center, it integrates clinical care and research in pediatric ophthalmology, including studies on atropine use and other myopia control strategies.
Key Differentiators
- Ophthalmology
- Pediatric Ophthalmology
- Myopia Management
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


